<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Psychiatry</journal-id><journal-title-group><journal-title>BMC Psychiatry</journal-title></journal-title-group><issn pub-type="epub">1471-244X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21943294</article-id><article-id pub-id-type="pmc">3187741</article-id><article-id pub-id-type="publisher-id">1471-244X-11-153</article-id><article-id pub-id-type="doi">10.1186/1471-244X-11-153</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Snow Control - An RCT protocol for a web-based self-help therapy to reduce cocaine consumption in problematic cocaine users</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Schaub</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>michael.schaub@isgf.uzh.ch</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Sullivan</surname><given-names>Robin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>robin.sullivan@isgf.uzh.ch</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Stark</surname><given-names>Lars</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>l.stark@arud-zh.ch</email></contrib></contrib-group><aff id="I1"><label>1</label>Research Institute for Public Health and Addiction, Zurich, Switzerland</aff><aff id="I2"><label>2</label>Working Group for the Low-Risk Use of Drugs, Zurich, Switzerland</aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>25</day><month>9</month><year>2011</year></pub-date><volume>11</volume><fpage>153</fpage><lpage>153</lpage><history><date date-type="received"><day>2</day><month>6</month><year>2011</year></date><date date-type="accepted"><day>25</day><month>9</month><year>2011</year></date></history><permissions><copyright-statement>Copyright Â©2011 Schaub et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder>Schaub et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-244X/11/153"></self-uri><abstract><sec><title><offsets xml_i="3038" xml_f="3048" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3059" xml_f="3642" txt_i="22" txt_f="605">Cocaine use has increased in most European countries, including Switzerland, and many states worldwide. The international literature has described treatment models that target the general population. In addition to supplying informative measures at the level of primary and secondary prevention, the literature also offers web-based self-help tools for problematic substance users, which is in line with tertiary prevention. Such programs, however, have been primarily tested on individuals with problematic alcohol and cannabis consumption, but not on cocaine-dependent individuals.</offsets></p></sec><sec><title><offsets xml_i="3664" xml_f="3678" txt_i="607" txt_f="621">Methods/Design</offsets></title><p><offsets xml_i="3689" xml_f="4485" txt_i="622" txt_f="1418">This paper presents the protocol of a randomised clinical trial to test the effectiveness of a web-based self-help therapy to reduce cocaine use in problematic cocaine users. The primary outcome is severity of cocaine dependence. Secondary outcome measures include cocaine craving, consumption of cocaine and other substances of abuse in the past month, and changes in depression characteristics. The therapy group will receive a 6-week self-help therapy to reduce cocaine consumption based on methods of Cognitive Behavioural Therapy, principles of Motivational Interviewing and self-control practices. The control group will be presented weekly psycho-educative information with a quiz. The predictive validity of participant characteristics on treatment retention and outcome will be explored.</offsets></p></sec><sec><title><offsets xml_i="4507" xml_f="4517" txt_i="1420" txt_f="1430">Discussion</offsets></title><p><offsets xml_i="4528" xml_f="4855" txt_i="1431" txt_f="1758">To the best of our knowledge, this will be the first randomised clinical trial to test the effectiveness of online self-help therapy to reduce or abstain from cocaine use. It will also investigate predictors of outcome and retention. This trial is registered at Current Controlled Trials and is traceable as NTR-ISRCTN93702927.</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="4917" xml_f="4927" txt_i="1767" txt_f="1777">Background</offsets></title><p><offsets xml_i="4938" xml_f="5186" txt_i="1778" txt_f="2026">Although data on the prevalence of problematic cocaine use and addiction are lacking in Switzerland and many other developed countries, there is no doubt that, in line with other countries, cocaine use has increased in Switzerland in recent years [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="5217" xml_f="5218" txt_i="2026" txt_f="2027">1</offsets></xref><offsets xml_i="5225" xml_f="5226" txt_i="2027" txt_f="2028">,</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="5257" xml_f="5258" txt_i="2028" txt_f="2029">2</offsets></xref><offsets xml_i="5265" xml_f="5405" txt_i="2029" txt_f="2169">]. Over the past ten years, the number of cocaine-related disorder treatments has quintupled in outpatient treatment and advisory services [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="5436" xml_f="5437" txt_i="2169" txt_f="2170">2</offsets></xref><offsets xml_i="5444" xml_f="5580" txt_i="2170" txt_f="2306">]. In 2005, resident institutions reported that, for the first time in history, cocaine outstripped opiates as the main substance used [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="5611" xml_f="5612" txt_i="2306" txt_f="2307">3</offsets></xref><offsets xml_i="5619" xml_f="5677" txt_i="2307" txt_f="2365">]. This trend has also been observed in outpatient units [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="5708" xml_f="5709" txt_i="2365" txt_f="2366">3</offsets></xref><offsets xml_i="5716" xml_f="5843" txt_i="2366" txt_f="2493">]. Further evidence of increased cocaine consumption has been found by quantifying cocaine concentrations in sewage effluents [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="5874" xml_f="5875" txt_i="2493" txt_f="2494">4</offsets></xref><offsets xml_i="5882" xml_f="5920" txt_i="2494" txt_f="2532">] and in recent HBSC student surveys [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="5951" xml_f="5952" txt_i="2532" txt_f="2533">5</offsets></xref><offsets xml_i="5959" xml_f="6237" txt_i="2533" txt_f="2811">]. The abovementioned increase in treatment requests likely reflects only a minority of cocaine users. Presumably, the majority of users consume cocaine on a quasi-controlled basis, whereas only a small fraction of consumers is likely to take advantage of available treatments [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="6268" xml_f="6269" txt_i="2811" txt_f="2812">6</offsets></xref><offsets xml_i="6276" xml_f="6367" txt_i="2812" txt_f="2903">]. However, it is expected that some users will switch from controlled to problematic use [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="6398" xml_f="6399" txt_i="2903" txt_f="2904">7</offsets></xref><offsets xml_i="6406" xml_f="6615" txt_i="2904" txt_f="3113">]. For those users, interventions that follow the principle of concurrent cover (i.e., non-invasive, low-cost interventions in which therapeutic intensity can be enhanced according to need) appear appropriate.</offsets></p><p><offsets xml_i="6622" xml_f="6960" txt_i="3114" txt_f="3452">In recent times, the international literature has described treatment models that target the general population. In addition to supplying informative measures at the level of primary and secondary prevention, the literature also offers web-based self-help tools for problematic substance users, which is in line with tertiary prevention [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="6991" xml_f="6992" txt_i="3452" txt_f="3453">8</offsets></xref><offsets xml_i="6999" xml_f="7000" txt_i="3453" txt_f="3454">-</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="7032" xml_f="7034" txt_i="3454" txt_f="3456">10</offsets></xref><offsets xml_i="7041" xml_f="7043" txt_i="3456" txt_f="3458">].</offsets></p><p><offsets xml_i="7050" xml_f="7267" txt_i="3459" txt_f="3676">Web-based self-help programs that reduce problematic consumption are able to reach "hidden" consumer groups in the general population due to their low treatment threshold and non-restrictive setting for intervention [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="7299" xml_f="7301" txt_i="3676" txt_f="3678">11</offsets></xref><offsets xml_i="7308" xml_f="7389" txt_i="3678" txt_f="3759">]. Furthermore, these programs show a remarkably positive cost-benefit relation [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="7421" xml_f="7423" txt_i="3759" txt_f="3761">12</offsets></xref><offsets xml_i="7430" xml_f="7702" txt_i="3761" txt_f="4033">], which is of interest in Switzerland and other industrialised countries suffering from exorbitant health costs. Such programs, however, have been primarily tested on individuals with problematic alcohol and cannabis consumption but not on cocaine-dependent individuals [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="7733" xml_f="7734" txt_i="4033" txt_f="4034">9</offsets></xref><offsets xml_i="7741" xml_f="7742" txt_i="4034" txt_f="4035">,</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="7774" xml_f="7776" txt_i="4035" txt_f="4037">10</offsets></xref><offsets xml_i="7783" xml_f="7784" txt_i="4037" txt_f="4038">,</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="7816" xml_f="7818" txt_i="4038" txt_f="4040">13</offsets></xref><offsets xml_i="7825" xml_f="7827" txt_i="4040" txt_f="4042">].</offsets></p><p><offsets xml_i="7834" xml_f="8126" txt_i="4043" txt_f="4335">Therefore, Snow Control, a six-week self-help therapy for problematic cocaine users who intend to reduce or stop consuming and have access to the Internet was developed in 2010. Snow Control is based on methods of Cognitive Behavioural Therapy (CBT) that have been tested on cocaine addicts [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="8158" xml_f="8160" txt_i="4335" txt_f="4337">14</offsets></xref><offsets xml_i="8167" xml_f="8168" txt_i="4337" txt_f="4338">,</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="8200" xml_f="8202" txt_i="4338" txt_f="4340">15</offsets></xref><offsets xml_i="8209" xml_f="8253" txt_i="4340" txt_f="4384">], principles of Motivational Interviewing [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="8285" xml_f="8287" txt_i="4384" txt_f="4386">16</offsets></xref><offsets xml_i="8294" xml_f="8374" txt_i="4386" txt_f="4466">], current self-control practices and the established Relapse-Prevention Model [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="8406" xml_f="8408" txt_i="4466" txt_f="4468">17</offsets></xref><offsets xml_i="8415" xml_f="8416" txt_i="4468" txt_f="4469">-</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="8448" xml_f="8450" txt_i="4469" txt_f="4471">19</offsets></xref><offsets xml_i="8457" xml_f="8459" txt_i="4471" txt_f="4473">].</offsets></p><p><offsets xml_i="8466" xml_f="8702" txt_i="4474" txt_f="4710">The therapy is structured into three parts and includes the following eight modules that are activated for access week by week (modules 1 to 4) and four additional voluntary modules (module 5 to 8) that can be activated during week 4-6:</offsets></p><p><offsets xml_i="8709" xml_f="8731" txt_i="4711" txt_f="4733">â¢ Part 1: Introduction</offsets></p><p><offsets xml_i="8738" xml_f="8760" txt_i="4734" txt_f="4756">â Registration process</offsets></p><p><offsets xml_i="8767" xml_f="8868" txt_i="4757" txt_f="4858">â Explanation of the cocaine consumption diary and its fully automated progress charts and statistics</offsets></p><p><offsets xml_i="8875" xml_f="8987" txt_i="4859" txt_f="4971">â Examination of the pros and cons resulting from a change in cocaine consumption patterns to address motivation</offsets></p><p><offsets xml_i="8994" xml_f="9200" txt_i="4972" txt_f="5178">â Explanation of the "My Snow Control" folder (This folder allows individuals to review the acquired summarised module documents, e.g., the list of the top five strategies for dealing with cocaine cravings)</offsets></p><p><offsets xml_i="9207" xml_f="9274" txt_i="5179" txt_f="5246">â¢ Part 2: Key Modules (to be worked through in the following order)</offsets></p><p><offsets xml_i="9281" xml_f="9324" txt_i="5247" txt_f="5290">â Module 1: Strategies for goal achievement</offsets></p><p><offsets xml_i="9331" xml_f="9370" txt_i="5291" txt_f="5330">â Module 2: Identifying risk situations</offsets></p><p><offsets xml_i="9377" xml_f="9417" txt_i="5331" txt_f="5371">â Module 3: Dealing with cocaine craving</offsets></p><p><offsets xml_i="9424" xml_f="9457" txt_i="5372" txt_f="5405">â Module 4: Dealing with relapses</offsets></p><p><offsets xml_i="9464" xml_f="9583" txt_i="5406" txt_f="5525">â¢ Part 3: Further Modules (to be worked through in optional order but with the recommendation to complete at least two)</offsets></p><p><offsets xml_i="9590" xml_f="9623" txt_i="5526" txt_f="5559">â Module 5: Enjoying leisure time</offsets></p><p><offsets xml_i="9630" xml_f="9662" txt_i="5560" txt_f="5592">â Module 6: Dealing with burdens</offsets></p><p><offsets xml_i="9669" xml_f="9717" txt_i="5593" txt_f="5641">â Module 7: Saying "no" to foster refusal skills</offsets></p><p><offsets xml_i="9724" xml_f="9759" txt_i="5642" txt_f="5677">â Module 8: Preserving achievements</offsets></p><p><offsets xml_i="9766" xml_f="10278" txt_i="5678" txt_f="6190">After the completion of part 1, each login in the therapy group will direct the participant to the consumption diary. The participants are asked to determine the amount of cocaine they plan to consume in the next 7 days and to specify the amount of cocaine consumed in the past 7 days into their consumption diary. After the completion of the consumption diary, they are directed to their weekly module (part 2 to be worked through in the above mentioned order; part 3 to be worked through in an optional order).</offsets></p><p><offsets xml_i="10285" xml_f="10905" txt_i="6191" txt_f="6811">To assess the effectiveness of the Snow Control therapy, an appropriate psycho-educative online control condition was developed. Participants in the control condition receive eight psycho-educative information modules on the risks, potential harms and other important information about cocaine consumption. The frequency of the control condition is comparable to the 6 weeks of intervention; however, it does not include the presentation of a consumption diary first. After having read each of the information modules, the participants are invited to participate in a weekly quiz to evaluate their information knowledge.</offsets></p></sec><sec><title><offsets xml_i="10927" xml_f="10941" txt_i="6813" txt_f="6827">Methods/Design</offsets></title><sec><title><offsets xml_i="10961" xml_f="10978" txt_i="6828" txt_f="6845">Aims of the trial</offsets></title><p><offsets xml_i="10989" xml_f="11634" txt_i="6846" txt_f="7491">This study aims to test the effectiveness of the web-based cognitive-behavioural self-help therapy Snow Control to reduce cocaine use in problematic cocaine users in a two-arm randomised controlled trial. The primary outcome is the change in severity of cocaine dependence between baseline, 3 and 6 weeks of therapy/intervention and at a 6-month follow up. The secondary outcome measures include changes in cocaine craving, the past month's consumption of cocaine and other substances of abuse and changes in depression characteristics. The predictive validity of participant characteristics for treatment retention and outcome will be explored.</offsets></p></sec><sec><title><offsets xml_i="11656" xml_f="11672" txt_i="7493" txt_f="7509">Study population</offsets></title><p><offsets xml_i="11683" xml_f="11930" txt_i="7510" txt_f="7757">The study population will be recruited through the Snow Control website, several websites from local outpatient treatment centres and from nightlife prevention websites. In addition, advertisements in Internet-forums and newspapers will be traced.</offsets></p></sec><sec><title><offsets xml_i="11952" xml_f="11962" txt_i="7759" txt_f="7769">Hypotheses</offsets></title><p><offsets xml_i="11973" xml_f="12111" txt_i="7770" txt_f="7908">We hypothesise that Snow Control participants in the therapy group will show higher reductions on the Severity of Dependence Scale (SDS) [</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="12143" xml_f="12145" txt_i="7908" txt_f="7910">20</offsets></xref><offsets xml_i="12152" xml_f="12552" txt_i="7910" txt_f="8310">] sum score and cocaine consumption than those in the control group at the 6-week treatment termination and at the 6-month follow up. Moreover, we expect participants in the therapy group to improve more significantly with respect to the secondary outcomes between baseline and 6-week treatment termination. We also expect the participants in the therapy group to show significantly higher retention.</offsets></p></sec><sec><title><offsets xml_i="12574" xml_f="12597" txt_i="8312" txt_f="8335">Measurement instruments</offsets></title><p><offsets xml_i="12608" xml_f="12939" txt_i="8336" txt_f="8667">The primary outcome instrument, the Severity of Dependence Scale (SDS), is a 5-item questionnaire that indicates the severity of dependence on cocaine. Each of the five items is scored on a 4-point scale (0-3). The total score is obtained through the addition of the 5 item ratings. High scores indicate a high level of dependency.</offsets></p><p><offsets xml_i="12946" xml_f="13067" txt_i="8668" txt_f="8789">Moreover, the following secondary outcome instruments will be applied: 1) The Cocaine Craving Questionnaire Brief CCQ-B [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="13099" xml_f="13101" txt_i="8789" txt_f="8791">21</offsets></xref><offsets xml_i="13108" xml_f="13192" txt_i="8791" txt_f="8875">] is a short (10 items) and validated instrument that was derived from the CCQ-Now [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="13224" xml_f="13226" txt_i="8875" txt_f="8877">22</offsets></xref><offsets xml_i="13233" xml_f="13596" txt_i="8877" txt_f="9240">] (45 items). It contains 10 craving symptoms that are rated on a 7-point Likert scale from strongly agree to strongly disagree. 2) The "Fragebogen Substanzanamnese" (FDA) ascertains the years of lifetime consumption, the past month's consumption, and the way of consumption for the DSM-IV/ICD-10 substances of abuse. This measure was derived from the EuropeASI [</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="13628" xml_f="13630" txt_i="9240" txt_f="9242">23</offsets></xref><offsets xml_i="13637" xml_f="13703" txt_i="9242" txt_f="9308">]. 3) The short version of the Beck Depression Inventory (BDI-V) [</offsets><xref ref-type="bibr" rid="B24"><offsets xml_i="13735" xml_f="13737" txt_i="9308" txt_f="9310">24</offsets></xref><offsets xml_i="13744" xml_f="14073" txt_i="9310" txt_f="9639">] is a derived, validated, and user-friendly short version of the classical Beck Depression Inventory. The BDI-V contains 20 items with a 6-point Likert scale (0/never-1-2-3-4-5/almost every time). Accordingly, the values range from 0 to 100, with a cut-off of 45 for a serious depressive episode that requires further treatment.</offsets></p></sec><sec><title><offsets xml_i="14095" xml_f="14150" txt_i="9641" txt_f="9696">Estimation of the Expected Effect Sizes and Sample Size</offsets></title><p><offsets xml_i="14161" xml_f="14823" txt_i="9697" txt_f="10359">The maximal SDS score is 15 points, and the average SDS standard deviation in previous studies was 5 points. As we expect relatively large cocaine consumption differences between participants, we expect a conservative SDS deviation of 7.5 points. For a successful reduction in cocaine use, an average 25% SDS score reduction (3.75 points reduction for a small to medium effect size) is anticipated. This results in a total sample of 25 participants in each group (Î± = .05, 1-Î² = 0.8). According to the pilot study, we expect 70% of the participants to quit the study before completion at six weeks. We thus aim to recruit a total of 170 participants at baseline.</offsets></p></sec><sec><title><offsets xml_i="14845" xml_f="14862" txt_i="10361" txt_f="10378">Consent Procedure</offsets></title><p><offsets xml_i="14873" xml_f="15133" txt_i="10379" txt_f="10639">The rationale of the study will be explained to the participants. They will also be informed about the different assessments, assessment schedules and duration. The participants will then be informed about (1) study inclusion and exclusion criteria (see table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="15165" xml_f="15166" txt_i="10639" txt_f="10640">1</offsets></xref><offsets xml_i="15173" xml_f="16072" txt_i="10640" txt_f="11539">), (2) the potential risks of participation, (3) safety arrangements during and after the study phase, (4) the inability of Snow Control to replace face-to-face therapy for problematic cocaine use/abuse, and (5) the circumstances under which they should contact their general practitioner or a professional from the medical advisory and emergency list that will be accessible at all times and how to make this contact. The participants will also be informed that the study has been reviewed by the ethic committee of the Canton of Zurich and given their declaration of no objection (nihil obstat). Moreover, they will be informed about their right to withdraw from the study at any time without consequences except for the loss of further compensation. Informed consent will be accepted when participants click on a field on the informed consent page and submit the consent with a submission button.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="16120" xml_f="16127" txt_i="11540" txt_f="11547">Table 1</offsets></label><caption><p><offsets xml_i="16147" xml_f="16193" txt_i="11547" txt_f="11593">Inclusion and exclusion criteria and reasoning</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><italic><offsets xml_i="16280" xml_f="16298" txt_i="11594" txt_f="11612">Inclusion Criteria</offsets></italic></th><th align="left"><offsets xml_i="16329" xml_f="16338" txt_i="11612" txt_f="11621">Reasoning</offsets></th></tr></thead><tbody><tr><td align="left"><offsets xml_i="16384" xml_f="16409" txt_i="11621" txt_f="11646">- Minimal age of 18 years</offsets></td><td align="left"><offsets xml_i="16431" xml_f="16471" txt_i="11647" txt_f="11687">To ensure a minimal age of participation</offsets></td></tr><tr><td align="left"><offsets xml_i="16502" xml_f="16552" txt_i="11688" txt_f="11735">- Cocaine use &gt; 2 occasions in the last 30 days</offsets></td><td align="left"><offsets xml_i="16574" xml_f="16645" txt_i="11736" txt_f="11807">To include occasional users in order to provide extended study validity</offsets></td></tr><tr><td align="left"><bold><italic><offsets xml_i="16690" xml_f="16708" txt_i="11808" txt_f="11826">Exclusion Criteria</offsets></italic></bold></td><td align="left"><bold><offsets xml_i="16752" xml_f="16761" txt_i="11827" txt_f="11836">Reasoning</offsets></bold></td></tr><tr><td align="left"><offsets xml_i="16799" xml_f="16910" txt_i="11837" txt_f="11948">- Participation in other psycho-social or pharmacological treatments for the reduction/cessation of cocaine use</offsets></td><td align="left"><offsets xml_i="16932" xml_f="16973" txt_i="11949" txt_f="11990">To avoid confounding of treatment effects</offsets></td></tr><tr><td align="left"><offsets xml_i="17004" xml_f="17145" txt_i="11991" txt_f="12132">- Opioid use in the last 30 days (exception: substitution maintenance treatment for opioid dependence without heroin use in the last 30 days)</offsets></td><td align="left"><offsets xml_i="17167" xml_f="17203" txt_i="12133" txt_f="12169">To avoid confounding of drug effects</offsets></td></tr><tr><td align="left"><offsets xml_i="17234" xml_f="17298" txt_i="12170" txt_f="12234">- Ever been in treatment for cardiovascular problems or apoplexy</offsets></td><td align="left"><offsets xml_i="17320" xml_f="17376" txt_i="12235" txt_f="12291">To avoid subjects with these problems entering the study</offsets></td></tr><tr><td align="left"><offsets xml_i="17407" xml_f="17428" txt_i="12292" txt_f="12310">- BDI-V score &gt; 45</offsets></td><td align="left"><offsets xml_i="17450" xml_f="17522" txt_i="12311" txt_f="12383">To avoid subjects with serious symptoms of depression entering the study</offsets></td></tr></tbody></table></table-wrap></sec><sec><title><offsets xml_i="17579" xml_f="17598" txt_i="12385" txt_f="12404">Baseline Assessment</offsets></title><p><offsets xml_i="17609" xml_f="18016" txt_i="12405" txt_f="12812">After providing informed consent, subjects who meet study entry criteria will create a personal and secure login and password (with automated real-time verification of the passwords' security level) and will receive an automated e-mail notification with their access information. They will then be directed to the baseline assessment on socio-demographic characteristics and consumption patterns (see table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="18048" xml_f="18049" txt_i="12812" txt_f="12813">2</offsets></xref><offsets xml_i="18056" xml_f="18156" txt_i="12813" txt_f="12913">). Participants that do not meet the inclusion and/or meet one of the exclusion criteria (see table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="18188" xml_f="18189" txt_i="12913" txt_f="12914">1</offsets></xref><offsets xml_i="18196" xml_f="18913" txt_i="12914" txt_f="13631">) will receive an explanation about why they are not permitted to participate in the study and be provided recommendations (e.g., not to reduce their consumption of cocaine before visiting a physician to receive more accurate treatment, etc.). A corresponding decision tree for the possible inclusion and exclusion criteria combinations will be constructed and implemented. The completion of the baseline assessment will allow participants to begin the Snow Control therapy or the control tool according to an automated online allocation procedure. Participants that do not fulfil the criteria can proceed with the Snow Control therapy modules, though without study participation (no assessments and no compensation).</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="18961" xml_f="18968" txt_i="13632" txt_f="13639">Table 2</offsets></label><caption><p><offsets xml_i="18988" xml_f="19016" txt_i="13639" txt_f="13667">Measurements and instruments</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><offsets xml_i="19095" xml_f="19118" txt_i="13668" txt_f="13691">Assessments/instruments</offsets></th><th align="left"><offsets xml_i="19140" xml_f="19148" txt_i="13691" txt_f="13699">Baseline</offsets></th><th align="left"><offsets xml_i="19170" xml_f="19177" txt_i="13699" txt_f="13706">3 weeks</offsets></th><th align="left"><offsets xml_i="19199" xml_f="19206" txt_i="13706" txt_f="13713">6 weeks</offsets></th><th align="left"><offsets xml_i="19228" xml_f="19245" txt_i="13713" txt_f="13730">6-month follow up</offsets></th></tr></thead><tbody><tr><td align="left"><offsets xml_i="19291" xml_f="19309" txt_i="13730" txt_f="13748">Socio-demographics</offsets></td><td align="left"><offsets xml_i="19331" xml_f="19332" txt_i="13749" txt_f="13750">x</offsets></td><td></td><td></td><td></td></tr><tr><td align="left"><offsets xml_i="19390" xml_f="19433" txt_i="13754" txt_f="13797">Previous psychiatric and somatic treatments</offsets></td><td align="left"><offsets xml_i="19455" xml_f="19456" txt_i="13798" txt_f="13799">x</offsets></td><td></td><td></td><td></td></tr><tr><td align="left"><offsets xml_i="19514" xml_f="19517" txt_i="13803" txt_f="13806">SDS</offsets></td><td align="left"><offsets xml_i="19539" xml_f="19540" txt_i="13807" txt_f="13808">x</offsets></td><td align="left"><offsets xml_i="19562" xml_f="19563" txt_i="13809" txt_f="13810">x</offsets></td><td align="left"><offsets xml_i="19585" xml_f="19586" txt_i="13811" txt_f="13812">x</offsets></td><td align="left"><offsets xml_i="19608" xml_f="19609" txt_i="13813" txt_f="13814">x</offsets></td></tr><tr><td align="left"><offsets xml_i="19640" xml_f="19645" txt_i="13815" txt_f="13820">CCQ-B</offsets></td><td align="left"><offsets xml_i="19667" xml_f="19668" txt_i="13821" txt_f="13822">x</offsets></td><td align="left"><offsets xml_i="19690" xml_f="19691" txt_i="13823" txt_f="13824">x</offsets></td><td align="left"><offsets xml_i="19713" xml_f="19714" txt_i="13825" txt_f="13826">x</offsets></td><td align="left"><offsets xml_i="19736" xml_f="19737" txt_i="13827" txt_f="13828">x</offsets></td></tr><tr><td align="left"><offsets xml_i="19768" xml_f="19771" txt_i="13829" txt_f="13832">FDA</offsets></td><td align="left"><offsets xml_i="19793" xml_f="19794" txt_i="13833" txt_f="13834">x</offsets></td><td align="left"><offsets xml_i="19816" xml_f="19817" txt_i="13835" txt_f="13836">x</offsets></td><td align="left"><offsets xml_i="19839" xml_f="19840" txt_i="13837" txt_f="13838">x</offsets></td><td align="left"><offsets xml_i="19862" xml_f="19863" txt_i="13839" txt_f="13840">x</offsets></td></tr><tr><td align="left"><offsets xml_i="19894" xml_f="19899" txt_i="13841" txt_f="13846">BDI-V</offsets></td><td align="left"><offsets xml_i="19921" xml_f="19922" txt_i="13847" txt_f="13848">x</offsets></td><td></td><td align="left"><offsets xml_i="19953" xml_f="19954" txt_i="13850" txt_f="13851">x</offsets></td><td align="left"><offsets xml_i="19976" xml_f="19977" txt_i="13852" txt_f="13853">x</offsets></td></tr></tbody></table></table-wrap></sec><sec><title><offsets xml_i="20034" xml_f="20062" txt_i="13855" txt_f="13883">Randomisation and Allocation</offsets></title><p><offsets xml_i="20073" xml_f="20635" txt_i="13884" txt_f="14446">Once participants have completed their baseline assessment, they will be randomly brought to part 1 of either the intervention or the control tool, and this assignment will be automatically registered in the background database. This assignment will also be registered in their Internet browser as a cookie to avoid multiple registrations by one person. If a person returns to the Snow Control start page and attempts to register for a second time, she or he will be recognised by the background database and automatically be redirected to his or her allocation.</offsets></p></sec><sec><title><offsets xml_i="20657" xml_f="20663" txt_i="14448" txt_f="14454">Safety</offsets></title><p><offsets xml_i="20674" xml_f="21156" txt_i="14455" txt_f="14937">During the 6-week therapy/intervention phase, participants will have the opportunity to contact a corresponding outpatient clinic in a nearby city by telephone (lists with opening hours, web-links, postal addresses, and telephone numbers will constantly be provided in the corresponding language). In addition, a medical advisory and emergency list in case of an emergency will be provided according to the web-based treatment guidelines from the Federation of Swiss Psychologists [</offsets><xref ref-type="bibr" rid="B25"><offsets xml_i="21188" xml_f="21190" txt_i="14937" txt_f="14939">25</offsets></xref><offsets xml_i="21197" xml_f="21226" txt_i="14939" txt_f="14968">] (in line with the HONcode [</offsets><xref ref-type="bibr" rid="B26"><offsets xml_i="21258" xml_f="21260" txt_i="14968" txt_f="14970">26</offsets></xref><offsets xml_i="21267" xml_f="21624" txt_i="14970" txt_f="15327">], a code of ethics for medical information on the Internet). This list will always be accessible before, during, and after (pdf-version for print out) the study participation regardless of whether they withdraw or drop out of the study. This list will include numbers of emergency help lines and the contact information of the study team and the webmaster.</offsets></p></sec><sec><title><offsets xml_i="21646" xml_f="21656" txt_i="15329" txt_f="15339">Trial Flow</offsets></title><p><offsets xml_i="21667" xml_f="21674" txt_i="15340" txt_f="15347">Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="21704" xml_f="21705" txt_i="15347" txt_f="15348">1</offsets></xref><offsets xml_i="21712" xml_f="23206" txt_i="15348" txt_f="16842"> provides an overview of the trial flow. If a participant successfully completes the baseline assessment (t0), he or she will be introduced step-by-step into either the intervention or the control tool (part 1) and invited to participate in module 1. Every week and two days in advance to the next module, a participant will receive an automated e-mail notification to login and return to the next module. Modules 1 to 4 will be accessible only week by week. After three weeks, the automated e-mail will direct the participant to the intermediate assessment (t1) before he or she has access to module 4 of the intervention or the control tool (end of part 2). Six weeks after the baseline assessment, completion of the additional optional modules of part 3 and weekly reminder e-mail notifications, participants will be invited again by e-mail to login and complete the final study assessment (t2). It is possible that some participants will wish to continue with some of the modules in part 3 after this period. However, the decision has been made to have the follow up timing depend solely on the time interval since t0. In our opinion, this is the best possible adherence to the 'intention to treat' principle. For the follow up assessment (t3), participants will be invited by an e-mail message 6 months past t0, with the notification that completion of the entire 6-month follow up assessment will be compensated by a 40 Euro incentive (an online voucher or an online charitable donation).</offsets></p><fig id="F1" position="float"><label><offsets xml_i="23247" xml_f="23255" txt_i="16843" txt_f="16851">Figure 1</offsets></label><caption><p><bold><offsets xml_i="23281" xml_f="23369" txt_i="16851" txt_f="16939">Trial flowchart. This figure provides an overview of the participant flow for this trial</offsets></bold><offsets xml_i="23376" xml_f="23377" txt_i="16939" txt_f="16940">.</offsets></p></caption><graphic xlink:href="1471-244X-11-153-1"></graphic></fig></sec><sec><title><offsets xml_i="23466" xml_f="23492" txt_i="16942" txt_f="16968">Handling of study dropouts</offsets></title><p><offsets xml_i="23503" xml_f="24108" txt_i="16969" txt_f="17574">Each week, participants will be sent an automated e-mail that contains a reminder to work on the next module and a direct link to the Snow Control login site. If participants do not log in, they will receive a reminder e-mail every three days within the following two weeks. If they do not continue their participation after these reminders, they will be considered to have dropped out of the study. Participants who skip one of the study questionnaires by not answering all of the questions will be identified in the data analyses and counted as dropout (cut-off: answered at least 70% of the questions).</offsets></p></sec><sec><title><offsets xml_i="24130" xml_f="24143" txt_i="17576" txt_f="17589">Data Analysis</offsets></title><p><offsets xml_i="24154" xml_f="24610" txt_i="17590" txt_f="18046">Data will be analysed according to the intention-to-treat principle. Multiple imputations of missing data handling procedures will be implemented using the statistical software package STATA (version 10). Baseline measurements will be compared using t- and Chi-squared tests. Differences between primary and secondary outcome variables at three and six weeks will be tested using a repeated measures ANOVA. Effect sizes will be calculated using Cohen's d [</offsets><xref ref-type="bibr" rid="B27"><offsets xml_i="24642" xml_f="24644" txt_i="18046" txt_f="18048">27</offsets></xref><offsets xml_i="24651" xml_f="25084" txt_i="18048" txt_f="18481">]. Differences in treatment retention will be tested using multiple logistic regression analyses. We will additionally conduct explorative regression analyses in order to test whether baseline variables predict cocaine abstinence, cocaine craving (CCQ-B), or reduced symptoms of depression (BDI-V). For these analyses, we will use linear, multinomial, or binary regression models dependent on the scale level of the outcome measures.</offsets></p></sec><sec><title><offsets xml_i="25106" xml_f="25120" txt_i="18483" txt_f="18497">Ethical Review</offsets></title><p><offsets xml_i="25131" xml_f="25331" txt_i="18498" txt_f="18698">This RCT will be executed in compliance to the Helsinki Declaration and has been reviewed by the ethic committee of the Canton of Zurich and given their declaration of no objection (KEK-StV-Nr.70/09).</offsets></p></sec></sec><sec><title><offsets xml_i="25359" xml_f="25369" txt_i="18701" txt_f="18711">Discussion</offsets></title><p><offsets xml_i="25380" xml_f="25958" txt_i="18712" txt_f="19290">To the best of our knowledge, this is the first randomised controlled trial to test the effectiveness of a web-based self-help therapy to reduce or abstain from cocaine use in problematic cocaine users. It will also be the first study to explore the predictors of outcome and retention in this type of therapy for problematic cocaine users. If the efficacy of this therapy is demonstrated in this RCT, Snow Control will be integrated into the basic services for cocaine users, and we will potentially be able to reach "hidden" cocaine consumer groups in the general population [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="25990" xml_f="25992" txt_i="19290" txt_f="19292">11</offsets></xref><offsets xml_i="25999" xml_f="26049" txt_i="19292" txt_f="19342">] in a remarkably positive cost-benefit relation [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="26081" xml_f="26083" txt_i="19342" txt_f="19344">12</offsets></xref><offsets xml_i="26090" xml_f="26092" txt_i="19344" txt_f="19346">].</offsets></p><p><offsets xml_i="26099" xml_f="26473" txt_i="19347" txt_f="19721">A specific problem includes the online implementation of informed consent. We will rely on participants to click on a field on the informed consent page and submit the consent with a submission button. We must thus trust that participants have read and understood the study information and that they are at least 18 years old. However, as we followed the considerations of [</offsets><xref ref-type="bibr" rid="B28"><offsets xml_i="26505" xml_f="26507" txt_i="19721" txt_f="19723">28</offsets></xref><offsets xml_i="26514" xml_f="26521" txt_i="19723" txt_f="19730">] and [</offsets><xref ref-type="bibr" rid="B29"><offsets xml_i="26553" xml_f="26555" txt_i="19730" txt_f="19732">29</offsets></xref><offsets xml_i="26562" xml_f="26860" txt_i="19732" txt_f="20030">] on how to best implement the informed consent procedure online, we expect the participants to give their full attention to reading the study information and providing informed consent. Nevertheless, the problem of minors under the age of 18 participating in the study cannot be addressed further.</offsets></p><p><offsets xml_i="26867" xml_f="27144" txt_i="20031" txt_f="20308">A further point of concern regarding the accuracy of the participants' online responses is the self-reported nature of online substance use information. A number of studies have shown that self-reported information regarding substance use, especially cocaine use, is reliable [</offsets><xref ref-type="bibr" rid="B30"><offsets xml_i="27176" xml_f="27178" txt_i="20308" txt_f="20310">30</offsets></xref><offsets xml_i="27185" xml_f="27186" txt_i="20310" txt_f="20311">-</offsets><xref ref-type="bibr" rid="B32"><offsets xml_i="27218" xml_f="27220" txt_i="20311" txt_f="20313">32</offsets></xref><offsets xml_i="27227" xml_f="27463" txt_i="20313" txt_f="20549">]. As participants provide substance use information within a secure password-protected online environment and presumably in a secure physical environment, such as at home in front of their own computers, we expect reliable information.</offsets></p><p><offsets xml_i="27470" xml_f="27799" txt_i="20550" txt_f="20879">Another point of concern is that the intended multivariate statistics rely considerably on a normal data distribution, and the data may be skewed as we defined frequencies of cocaine consumption in the inclusion criteria. Therefore, multivariate statistics should be performed with caution. As suggested by our Dutch colleagues [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="27830" xml_f="27831" txt_i="20879" txt_f="20880">8</offsets></xref><offsets xml_i="27838" xml_f="28059" txt_i="20880" txt_f="21101">] in their RCT protocol for the evaluation of real-time internet therapy vs. online self-help for problematic alcohol users, we will utilise bootstrap methods and permutation tests according to Hesterberg and colleagues [</offsets><xref ref-type="bibr" rid="B33"><offsets xml_i="28091" xml_f="28093" txt_i="21101" txt_f="21103">33</offsets></xref><offsets xml_i="28100" xml_f="28102" txt_i="21103" txt_f="21105">].</offsets></p><p><offsets xml_i="28109" xml_f="28774" txt_i="21106" txt_f="21771">During the online implementation of the consumption diary of the Snow Control therapy group, we considered asking pilot participants to note the number of cocaine lines consumed. The pilot tests showed that although this includes some numeracy skills, pilot participants did not feel disturbed to note their consumption in grams of cocaine consumed per day. However, because the well-established SDS is utilised as the main outcome and the CCQ-B as a secondary instrument with a randomised control group, we do not expect much influence of purity and quality of the cocaine consumed or the methods of consumption to interfere with the potential outcome differences.</offsets></p><p><offsets xml_i="28781" xml_f="29560" txt_i="21772" txt_f="22551">Finally, a potential problem for this trial is the expected high number of lost participants at the end of and at follow up of the online therapy, which will likely be even higher in the control intervention. We will address this issue in three ways. 1) All participants must invest approximately 30 minutes for the baseline assessment, which will select rather motivated participants and prevent the participation of un-motivated participants. 2) Participation at 6 months follow up assessment will be compensated by a 40 Euro incentive (an online voucher or an online charitable donation). 3) All missing values in the final data set will be multiple-imputed, a promising approach that, as shown by our Dutch colleagues, has become increasingly important in e-health research [</offsets><xref ref-type="bibr" rid="B34"><offsets xml_i="29592" xml_f="29594" txt_i="22551" txt_f="22553">34</offsets></xref><offsets xml_i="29601" xml_f="29603" txt_i="22553" txt_f="22555">].</offsets></p></sec><sec><title><offsets xml_i="29625" xml_f="29644" txt_i="22557" txt_f="22576">Competing interests</offsets></title><p><offsets xml_i="29655" xml_f="29804" txt_i="22577" txt_f="22726">The authors declare that they have no competing interests. This trial is registered at Current Controlled Trials and traceable as NTR-ISRCTN93702927.</offsets></p></sec><sec><title><offsets xml_i="29826" xml_f="29848" txt_i="22728" txt_f="22750">Authors' contributions</offsets></title><p><offsets xml_i="29859" xml_f="30189" txt_i="22751" txt_f="23081">MS was responsible for the study design, prepared the first draft of the paper and the final manuscript. MS, RS and LS developed the Snow Control self-help therapy and the control condition. RS programmed and implemented the study website. All of the authors approved the final version of the manuscript submitted for publication.</offsets></p></sec><sec><title><offsets xml_i="30211" xml_f="30234" txt_i="23083" txt_f="23106">Pre-publication history</offsets></title><p><offsets xml_i="30245" xml_f="30309" txt_i="23107" txt_f="23171">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-244X/11/153/prepub"><offsets xml_i="30412" xml_f="30464" txt_i="23172" txt_f="23224">http://www.biomedcentral.com/1471-244X/11/153/prepub</offsets></ext-link></p></sec></body><back><sec><title>Acknowledgements</title><p>Funding for this study was provided by the Swiss Office for the Coordination of Addiction Facilities Infodrog (Grant Nr. 4962/09/ZHZ/WSOK) and the Association for Drug Related Work from the city of Basel, Switzerland. Particular appreciation goes out to the staff of the Working Group for the Low-Risk Use of Drugs from Zurich Switzerland and their patients who voluntarily participated in the pilot testing of the Snow Control therapy and the control intervention.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Bruggisser</surname><given-names>M</given-names></name><name><surname>Ceschi</surname><given-names>A</given-names></name><name><surname>Bodmer</surname><given-names>M</given-names></name><name><surname>Wilks</surname><given-names>MF</given-names></name><name><surname>Kupferschmidt</surname><given-names>H</given-names></name><name><surname>Liechti</surname><given-names>ME</given-names></name><article-title>Retrospective analysis of stimulant abuse cases reported to the Swiss Toxicological Information Centre during 1997-2009</article-title><source>Swiss Med Wkly</source><year>2010</year><volume>140</volume><fpage>w13115</fpage><pub-id pub-id-type="pmid">21188679</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="other"><name><surname>Maag</surname><given-names>V</given-names></name><article-title>Kokain - die neue Volksdroge? Nationale und internationale Trends</article-title><source>AbhÃ¤ngigkeiten</source><year>2006</year><fpage>13</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">21926583</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="book"><collab>Act-info</collab><source>Act-info Jahresbericht 2010 - Suchtberatung und Suchtbehandlung in der Schweiz. Ergebnisse des Monitoringsystems</source><year>2011</year><publisher-name>Bern: Bundesamt fÃ¼r Gesundheit</publisher-name></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="book"><collab>UNODC</collab><source>World Drug Report</source><year>2007</year><publisher-name>United Nations, Office on Drug Crime</publisher-name></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="book"><name><surname>Schmid</surname><given-names>H</given-names></name><name><surname>Delgrande-Jordan</surname><given-names>M</given-names></name><source>Der Konsum psychoaktiver Substanzen von SchÃ¼lerinnen und SchÃ¼lern in der Schweiz - AusgewÃ¤hlte Ergebnisse einer Studie, durchgefÃ¼hrt unter der Schirmherrschaft der Weltgesundheitsorganisation (WHO) (Forschungsbericht Nr. 42)</source><year>2007</year><publisher-name>Lausanne: Schweizerische Fachstelle fÃ¼r Alkohol- und andere Drogenprobleme (SFA)</publisher-name></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Prinzleve</surname><given-names>M</given-names></name><name><surname>Haasen</surname><given-names>C</given-names></name><name><surname>Zurhold</surname><given-names>H</given-names></name><name><surname>Matali</surname><given-names>JL</given-names></name><name><surname>Bruguera</surname><given-names>E</given-names></name><name><surname>Gerevich</surname><given-names>J</given-names></name><name><surname>BÃ¡cskai</surname><given-names>E</given-names></name><name><surname>Ryder</surname><given-names>N</given-names></name><name><surname>Butler</surname><given-names>S</given-names></name><name><surname>Manning</surname><given-names>V</given-names></name><name><surname>Gossop</surname><given-names>M</given-names></name><name><surname>Am Pezous</surname></name><name><surname>Verster</surname><given-names>A</given-names></name><name><surname>Camposeragna</surname><given-names>A</given-names></name><name><surname>Andersson</surname><given-names>P</given-names></name><name><surname>Olsson</surname><given-names>B</given-names></name><name><surname>Primorac</surname><given-names>A</given-names></name><name><surname>Fischer</surname><given-names>G</given-names></name><name><surname>GÃ¼ttinger</surname><given-names>F</given-names></name><name><surname>Rehm</surname><given-names>J</given-names></name><name><surname>Krausz</surname><given-names>M</given-names></name><article-title>Cocaine use in Europe - a multi-centre study: patterns of use in different groups</article-title><source>Eur Addict Res</source><year>2004</year><volume>10</volume><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1159/000079835</pub-id><pub-id pub-id-type="pmid">15367815</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Haasen</surname><given-names>C</given-names></name><name><surname>Prinzleve</surname><given-names>M</given-names></name><name><surname>Zurhold</surname><given-names>H</given-names></name><name><surname>Rehm</surname><given-names>J</given-names></name><name><surname>GÃ¼ttinger</surname><given-names>F</given-names></name><name><surname>Fischer</surname><given-names>G</given-names></name><name><surname>Jagsch</surname><given-names>R</given-names></name><name><surname>Olsson</surname><given-names>B</given-names></name><name><surname>Ekendahl</surname><given-names>M</given-names></name><name><surname>Verster</surname><given-names>A</given-names></name><name><surname>Camposeragna</surname><given-names>A</given-names></name><name><surname>Pezous</surname><given-names>A</given-names></name><name><surname>Gossop</surname><given-names>M</given-names></name><name><surname>Manning</surname><given-names>V</given-names></name><name><surname>Cox</surname><given-names>G</given-names></name><name><surname>Ryder</surname><given-names>N</given-names></name><name><surname>Gerevich</surname><given-names>J</given-names></name><name><surname>Bacskai</surname><given-names>E</given-names></name><name><surname>Casas</surname><given-names>M</given-names></name><name><surname>Matali</surname><given-names>JL</given-names></name><name><surname>Krausz</surname><given-names>M</given-names></name><article-title>Cocaine use in Europe - a multi-centre study. Methodology and prevalence estimates</article-title><source>Eur Addict Res</source><year>2004</year><volume>10</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1159/000079834</pub-id><pub-id pub-id-type="pmid">15367814</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Blankers</surname><given-names>M</given-names></name><name><surname>Koeter</surname><given-names>M</given-names></name><name><surname>Schippers</surname><given-names>GM</given-names></name><article-title>Evaluating real-time internet therapy and online self-help for problematic alcohol consumers: a three-arm RCT protocol</article-title><source>BMC Public Health</source><year>2009</year><volume>9</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-9-16</pub-id><pub-id pub-id-type="pmid">19144162</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Postel</surname><given-names>MG</given-names></name><name><surname>de Haan</surname><given-names>HA</given-names></name><name><surname>ter</surname><given-names>HED</given-names></name><name><surname>Becker</surname><given-names>ES</given-names></name><name><surname>de Jong</surname><given-names>CA</given-names></name><article-title>Effectiveness of a web-based intervention for problem drinkers and reasons for dropout: randomized controlled trial</article-title><source>J Med Internet Res</source><year>2010</year><volume>12</volume><fpage>e68</fpage><pub-id pub-id-type="pmid">21163776</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Riper</surname><given-names>H</given-names></name><name><surname>Kramer</surname><given-names>J</given-names></name><name><surname>Smit</surname><given-names>F</given-names></name><name><surname>Conijn</surname><given-names>B</given-names></name><name><surname>Schippers</surname><given-names>G</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name><article-title>Web-based self-help for problem drinkers: a pragmatic randomized trial</article-title><source>Addiction</source><year>2008</year><volume>103</volume><fpage>218</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.2007.02063.x</pub-id><pub-id pub-id-type="pmid">18199300</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Cunningham</surname><given-names>JA</given-names></name><name><surname>Humphreys</surname><given-names>K</given-names></name><name><surname>Koski-Jannes</surname><given-names>A</given-names></name><name><surname>Cordingley</surname><given-names>J</given-names></name><article-title>Internet and paper self-help materials for problem drinking: is there an additive effect?</article-title><source>Addict Behav</source><year>2005</year><volume>30</volume><fpage>1517</fpage><lpage>1523</lpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2005.03.003</pub-id><pub-id pub-id-type="pmid">15893433</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Curry</surname><given-names>SJ</given-names></name><article-title>eHealth research and healthcare delivery beyond intervention effectiveness</article-title><source>Am J Prev Med</source><year>2007</year><volume>32</volume><fpage>S127</fpage><lpage>S130</lpage><pub-id pub-id-type="doi">10.1016/j.amepre.2007.01.026</pub-id><pub-id pub-id-type="pmid">17466817</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Copeland</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>G</given-names></name><article-title>Web-based interventions for substance use disorders: a qualitative review</article-title><source>J Subst Abuse Treat</source><year>2004</year><volume>26</volume><fpage>109</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/S0740-5472(03)00165-X</pub-id><pub-id pub-id-type="pmid">15050088</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Carroll</surname><given-names>KM</given-names></name><name><surname>Rounsaville</surname><given-names>BJ</given-names></name><name><surname>Nich</surname><given-names>C</given-names></name><name><surname>Gordon</surname><given-names>LT</given-names></name><name><surname>Wirtz</surname><given-names>PW</given-names></name><name><surname>Gawin</surname><given-names>F</given-names></name><article-title>One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects</article-title><source>Arch Gen Psychiatry</source><year>1994</year><volume>51</volume><fpage>989</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">7979888</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Carroll</surname><given-names>KM</given-names></name><article-title>Recent advances in the psychotherapy of addictive disorders</article-title><source>Curr Psychiatry Rep</source><year>2005</year><volume>7</volume><fpage>329</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1007/s11920-005-0032-5</pub-id><pub-id pub-id-type="pmid">16216150</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>McKee</surname><given-names>SA</given-names></name><name><surname>Carroll</surname><given-names>KM</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Robinson</surname><given-names>JE</given-names></name><name><surname>Nich</surname><given-names>C</given-names></name><name><surname>Cavallo</surname><given-names>D</given-names></name><name><surname>O'Malley</surname><given-names>S</given-names></name><article-title>Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine users</article-title><source>Drug Alcohol Depend</source><year>2007</year><volume>91</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2007.05.006</pub-id><pub-id pub-id-type="pmid">17573205</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="book"><name><surname>Sobell</surname><given-names>MB</given-names></name><name><surname>Sobell</surname><given-names>LC</given-names></name><source>Problem drinkers: Guided self-change treatment</source><year>1993</year><publisher-name>New York: Guilford Press</publisher-name></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="book"><name><surname>Sanchez-Craig</surname><given-names>M</given-names></name><source>Saying When: How to Quit Drinking or Cut Down</source><year>1993</year><publisher-name>Toronto: Addiction Research Foundation</publisher-name></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Velicer</surname><given-names>WF</given-names></name><name><surname>Diclemente</surname><given-names>CC</given-names></name><name><surname>Rossi</surname><given-names>JS</given-names></name><name><surname>Prochaska</surname><given-names>JO</given-names></name><article-title>Relapse situations and self-efficacy: an integrative model</article-title><source>Addict Behav</source><year>1990</year><volume>15</volume><fpage>271</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/0306-4603(90)90070-E</pub-id><pub-id pub-id-type="pmid">2378287</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Gossop</surname><given-names>M</given-names></name><name><surname>Darke</surname><given-names>S</given-names></name><name><surname>Griffiths</surname><given-names>P</given-names></name><name><surname>Hando</surname><given-names>J</given-names></name><name><surname>Powis</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>W</given-names></name><name><surname>Strang</surname><given-names>J</given-names></name><article-title>The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users</article-title><source>Addiction</source><year>1995</year><volume>90</volume><fpage>607</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.1995.tb02199.x</pub-id><pub-id pub-id-type="pmid">7795497</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Sussner</surname><given-names>BD</given-names></name><name><surname>Smelson</surname><given-names>DA</given-names></name><name><surname>Rodrigues</surname><given-names>S</given-names></name><name><surname>Kline</surname><given-names>A</given-names></name><name><surname>Losonczy</surname><given-names>M</given-names></name><name><surname>Ziedonis</surname><given-names>D</given-names></name><article-title>The validity and reliability of a brief measure of cocaine craving</article-title><source>Drug Alcohol Depend</source><year>2006</year><volume>83</volume><fpage>233</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2005.11.022</pub-id><pub-id pub-id-type="pmid">16384655</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Tiffany</surname><given-names>ST</given-names></name><name><surname>Singleton</surname><given-names>E</given-names></name><name><surname>Haertzen</surname><given-names>CA</given-names></name><name><surname>Henningfield</surname><given-names>JE</given-names></name><article-title>The development of a cocaine craving questionnaire</article-title><source>Drug Alcohol Depend</source><year>1993</year><volume>34</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/0376-8716(93)90042-O</pub-id><pub-id pub-id-type="pmid">8174499</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Kokkevi</surname><given-names>A</given-names></name><name><surname>Hartgers</surname><given-names>C</given-names></name><article-title>Europe ASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence</article-title><source>Eur Addict Res</source><year>1995</year><volume>1</volume><fpage>208</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1159/000259089</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Schmitt</surname><given-names>M</given-names></name><name><surname>AltstÃ¶tter-Gleich</surname><given-names>C</given-names></name><name><surname>Hinz</surname><given-names>A</given-names></name><name><surname>Maes</surname><given-names>J</given-names></name><name><surname>BrÃ¤hler</surname><given-names>E</given-names></name><article-title>Normwerte fÃ¼r das Vereinfachte Beck-Depressions-Inventar (BDI-V) in der AllgemeinbevÃ¶lkerung</article-title><source>Diagnostica</source><year>2006</year><volume>52</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1026/0012-1924.52.2.51</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="other"><collab>FÃ¶deration der Schweizer Psychologinnen und Psychologen FSP</collab><article-title>QualitÃ¤tskriterien fÃ¼r psychologische Angebote im Internet</article-title><ext-link ext-link-type="uri" xlink:href="http://www.psychologie.ch/fileadmin/user_upload/dokumente/berufspolitik/d-qual-krit-inet-06.pdf">http://www.psychologie.ch/fileadmin/user_upload/dokumente/berufspolitik/d-qual-krit-inet-06.pdf</ext-link></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="other"><collab>Health on the Net Foundation HON</collab><article-title>The HON Code of Conduct for medical and health Web sites (HONcode)</article-title><ext-link ext-link-type="uri" xlink:href="http://www.hon.ch/HONcode/Conduct.html">http://www.hon.ch/HONcode/Conduct.html</ext-link></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="book"><name><surname>Cohen</surname><given-names>J</given-names></name><source>Statistical power analysis for the behavioral sciences</source><year>1988</year><edition>2</edition><publisher-name>Hillsdale, NJ: L. Erlbaum Associates</publisher-name></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Keller</surname><given-names>HE</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><article-title>Ethical issues surrounding human participants research using the Internet</article-title><source>Ethics Behav</source><year>2003</year><volume>13</volume><fpage>211</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1207/S15327019EB1303_01</pub-id><pub-id pub-id-type="pmid">14680001</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Varnhagen</surname><given-names>CK</given-names></name><name><surname>Gushta</surname><given-names>M</given-names></name><name><surname>Daniels</surname><given-names>J</given-names></name><name><surname>Peters</surname><given-names>TC</given-names></name><name><surname>Parmar</surname><given-names>N</given-names></name><name><surname>Law</surname><given-names>D</given-names></name><name><surname>Hirsch</surname><given-names>R</given-names></name><name><surname>Sadler Takach</surname><given-names>B</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><article-title>How informed is online informed consent?</article-title><source>Ethics Behav</source><year>2005</year><volume>15</volume><fpage>37</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1207/s15327019eb1501_3</pub-id><pub-id pub-id-type="pmid">16127857</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Vitale</surname><given-names>SG</given-names></name><name><surname>van de Mheen</surname><given-names>H</given-names></name><name><surname>van de Wiel</surname><given-names>A</given-names></name><name><surname>Garretsen</surname><given-names>HF</given-names></name><article-title>Substance use among emergency room patients: Is self-report preferable to biochemical markers?</article-title><source>Addict Behav</source><year>2006</year><volume>31</volume><fpage>1661</fpage><lpage>1669</lpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2005.12.011</pub-id><pub-id pub-id-type="pmid">16446045</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Calhoun</surname><given-names>PS</given-names></name><name><surname>Sampson</surname><given-names>WS</given-names></name><name><surname>Bosworth</surname><given-names>HB</given-names></name><name><surname>Feldman</surname><given-names>ME</given-names></name><name><surname>Kirby</surname><given-names>AC</given-names></name><name><surname>Hertzberg</surname><given-names>MA</given-names></name><name><surname>Wampler</surname><given-names>TP</given-names></name><name><surname>Tate-Williams</surname><given-names>F</given-names></name><name><surname>Moore</surname><given-names>SD</given-names></name><name><surname>Beckham</surname><given-names>JC</given-names></name><article-title>Drug use and validity of substance use self-reports in veterans seeking help for posttraumatic stress disorder</article-title><source>J Consult Clin Psychol</source><year>2000</year><volume>68</volume><fpage>923</fpage><lpage>927</lpage><pub-id pub-id-type="pmid">11068979</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Zaldivar</surname><given-names>BF</given-names></name><name><surname>Garcia</surname><given-names>MJM</given-names></name><name><surname>Flores</surname><given-names>CP</given-names></name><name><surname>Sanchez</surname><given-names>SF</given-names></name><name><surname>Lopez</surname><given-names>RF</given-names></name><name><surname>Molina</surname><given-names>MA</given-names></name><article-title>Validity of the self-report on drug use by university students: correspondence between self-reported use and use detected in urine</article-title><source>Psicothema</source><year>2009</year><volume>21</volume><fpage>213</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">19403073</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="book"><name><surname>Hesterberg</surname><given-names>T</given-names></name><name><surname>Moore</surname><given-names>DS</given-names></name><name><surname>Monaghan</surname><given-names>S</given-names></name><name><surname>Clipson</surname><given-names>A</given-names></name><name><surname>Epstein</surname><given-names>R</given-names></name><person-group person-group-type="editor">Moore DS, MacCabe GP</person-group><article-title>Bootstrap Methods and Permutation Tests</article-title><source>Introduction to the Practice of Statistics</source><year>2005</year><volume>14</volume><edition>5</edition><publisher-name>New York: WH Freeman &amp; Company</publisher-name><fpage>1</fpage><lpage>70</lpage></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Blankers</surname><given-names>M</given-names></name><name><surname>Koeter</surname><given-names>MW</given-names></name><name><surname>Schippers</surname><given-names>GM</given-names></name><article-title>Missing data approaches in eHealth research: simulation study and a tutorial for nonmathematically inclined researchers</article-title><source>J Med Internet Res</source><year>2010</year><volume>12</volume><fpage>e54</fpage><pub-id pub-id-type="pmid">21169167</pub-id></mixed-citation></ref></ref-list></back></article>